2-(5-(4-Fluorobenzylidene)-2,4-dioxothiazolidin-3-yl)-N-(4-chlorophenyl)acetamide

ID: ALA4554145

PubChem CID: 1583408

Max Phase: Preclinical

Molecular Formula: C18H12ClFN2O3S

Molecular Weight: 390.82

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CN1C(=O)S/C(=C\c2ccc(F)cc2)C1=O)Nc1ccc(Cl)cc1

Standard InChI:  InChI=1S/C18H12ClFN2O3S/c19-12-3-7-14(8-4-12)21-16(23)10-22-17(24)15(26-18(22)25)9-11-1-5-13(20)6-2-11/h1-9H,10H2,(H,21,23)/b15-9-

Standard InChI Key:  HVSNYQQANCAZFS-DHDCSXOGSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
   26.2655  -24.4017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0868  -24.4017    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.3453  -23.6209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6782  -23.1346    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   26.0154  -23.6209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2339  -23.3687    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0637  -22.5653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6767  -22.0150    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5028  -21.2123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.7207  -20.9594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1123  -21.5113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2852  -22.3119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1229  -23.3694    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.5705  -25.0675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3875  -24.9831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8670  -25.6489    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.6840  -25.5603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1635  -26.2268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9797  -26.1428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3137  -25.3919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8295  -24.7242    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0150  -24.8115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7207  -24.2328    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.7843  -25.0664    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.1264  -25.3067    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   24.5488  -20.1605    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3 13  2  0
  2 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 15 23  2  0
  1 24  2  0
 20 25  1  0
 10 26  1  0
M  END

Associated Targets(non-human)

NS5B Hepatitis C virus NS5B RNA-dependent RNA polymerase (3026 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.82Molecular Weight (Monoisotopic): 390.0241AlogP: 4.15#Rotatable Bonds: 4
Polar Surface Area: 66.48Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.15CX Basic pKa: CX LogP: 3.73CX LogD: 3.73
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.80Np Likeness Score: -2.35

References

1. Hassan GS, Georgey HH, Mohammed EZ, Omar FA..  (2019)  Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors.,  184  [PMID:31604164] [10.1016/j.ejmech.2019.111747]

Source